Effect of Gemfibrozil on HDL-Associated Serum Paraoxonase Activity and Lipoprotein Profile in Patients with Hyperlipidaemia

This publication has 25 references indexed in Scilit:

• Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia
  Atherosclerosis, 1994
• Is paraoxonase related to atherosclerosis
  Chemico-Biological Interactions, 1993
• Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)
  The American Journal of Cardiology, 1992
• Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins
  Clinical Genetics, 1991
• The Helsinki Heart Study: Central Findings and Clinical Implications
  Annals of Medicine, 1991
• High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
• Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients
  Atherosclerosis, 1988
• The triglyceride issue: A view from Framingham
  American Heart Journal, 1986
• Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
  New England Journal of Medicine, 1984
• LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture
  Atherosclerosis, 1979